These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20191867)

  • 41. Associations between circulating N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings.
    Pervanidou P; Margeli A; Akalestos A; Sakka S; Kanaka-Gantenbein C; Papassotiriou I; Chrousos GP
    Horm Metab Res; 2009 Nov; 41(11):829-33. PubMed ID: 19670155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating adipocytokines in obese nondiabetic patients in relationship with cardiovascular risk factors, anthropometry and resting-energy expenditure.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O; Romero E
    Ann Nutr Metab; 2007; 51(5):416-20. PubMed ID: 18025813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.
    Després JP
    J Endocrinol Invest; 2006; 29(3 Suppl):77-82. PubMed ID: 16751711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity and the obesity paradox in heart failure.
    Gupta PP; Fonarow GC; Horwich TB
    Can J Cardiol; 2015 Feb; 31(2):195-202. PubMed ID: 25661554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity.
    Ozeke O; Ozer C; Gungor M; Celenk MK; Dincer H; Ilicin G
    Med Hypotheses; 2011 Jan; 76(1):61-3. PubMed ID: 20822856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Obesity and the prognosis of heart failure: the obesity paradox, myth or reality?].
    Bounhoure JP; Galinier M; Roncalli J; Massabuau P
    Bull Acad Natl Med; 2014 Jan; 198(1):61-9; discussion 69-70. PubMed ID: 26259287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of adipokines in obesity-associated hypertension.
    Vlasova M; Purhonen AK; Jarvelin MR; Rodilla E; Pascual J; Herzig KH
    Acta Physiol (Oxf); 2010 Oct; 200(2):107-27. PubMed ID: 20653609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity paradox in different populations: evidence and controversies.
    Goel K; Lopez-Jimenez F; De Schutter A; Coutinho T; Lavie CJ
    Future Cardiol; 2014 Jan; 10(1):81-91. PubMed ID: 24344665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The obesity paradox: methodological considerations based on epidemiological and clinical evidence--new insights.
    Kastorini CM; Panagiotakos DB
    Maturitas; 2012 Jul; 72(3):220-4. PubMed ID: 22609156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases.
    Artham SM; Lavie CJ; Milani RV; Ventura HO
    Postgrad Med; 2008 Jul; 120(2):34-41. PubMed ID: 18654066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weight loss is a useful therapeutic objective.
    Kramer CK
    Can J Cardiol; 2015 Feb; 31(2):211-5. PubMed ID: 25661556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.
    Maresca F; Di Palma V; Bevilacqua M; Uccello G; Taglialatela V; Giaquinto A; Esposito G; Trimarco B; Cirillo P
    Angiology; 2015 Jan; 66(1):8-24. PubMed ID: 24535638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The obesity paradox: an endocrine perspective.
    Cheung YM; Joham A; Marks S; Teede H
    Intern Med J; 2017 Jul; 47(7):727-733. PubMed ID: 27643504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and target organ damage: the heart.
    Schunkert H
    Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S15-20. PubMed ID: 12457294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The paradox of obesity and cardiovascular disease risk: time to change labels.
    Vincent J
    Clin Pharmacol Ther; 2011 Jul; 90(1):3-9. PubMed ID: 21691265
    [No Abstract]   [Full Text] [Related]  

  • 57. The obesity paradox.
    Amundson DE; Djurkovic S; Matwiyoff GN
    Crit Care Clin; 2010 Oct; 26(4):583-96. PubMed ID: 20970043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The obesity paradox.
    Taylor J
    Eur Heart J; 2011 Jul; 32(13):1575-6. PubMed ID: 21853557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated.
    Lavie CJ; De Schutter A; Parto P; Jahangir E; Kokkinos P; Ortega FB; Arena R; Milani RV
    Prog Cardiovasc Dis; 2016; 58(5):537-47. PubMed ID: 26826295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Updates on obesity and the obesity paradox in cardiovascular diseases.
    Tutor AW; Lavie CJ; Kachur S; Milani RV; Ventura HO
    Prog Cardiovasc Dis; 2023; 78():2-10. PubMed ID: 36481212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.